These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1975199)

  • 41. Continuous alpha 2-adrenoceptor blockade by atipamezole decreases neocortical high-voltage spindle activity in rats.
    Jäkälä P; Viitamaa T; Sirviö J; Riekkinen P; Salonen J; Haapalinna A; Virtanen R; Riekkinen P
    Eur J Pharmacol; 1992 Oct; 221(2-3):351-7. PubMed ID: 1358656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medetomidine premedication in dental surgery--a double-blind cross-over study with a new alpha 2-adrenoceptor agonist.
    Kallio A; Salonen M; Forssell H; Scheinin H; Scheinin M; Tuominen J
    Acta Anaesthesiol Scand; 1990 Apr; 34(3):171-5. PubMed ID: 1971472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversal of medetomidine sedation in sheep by atipamezole and yohimbine.
    Mohammad FK; Zangana IK; Abdul-Latif AR
    Vet Hum Toxicol; 1995 Apr; 37(2):97-9. PubMed ID: 7631500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: II. Duration of action, pharmacokinetics and concentration-effect relationships in normotensive subjects.
    Schafers RF; Elliott HL; Meredith PA; Miller SH; Reid JL
    Br J Clin Pharmacol; 1991 Nov; 32(5):605-10. PubMed ID: 1683250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alpha 2-adrenoceptor-blocking properties of midaglizole (DG-5128) in rats.
    Hirohashi M; Tanaka M; Suzuki I; Akashi A
    Arch Int Pharmacodyn Ther; 1990; 306():75-86. PubMed ID: 1981668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toxicity and kinetics of amitraz in dogs.
    Hugnet C; Buronrosse F; Pineau X; Cadoré JL; Lorgue G; Berny PJ
    Am J Vet Res; 1996 Oct; 57(10):1506-10. PubMed ID: 8896693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased sexual behavior in male Macaca arctoides monkeys produced by atipamezole, a selective alpha 2-adrenoceptor antagonist.
    Linnankoski I; Grönroos M; Carlson S; Pertovaara A
    Pharmacol Biochem Behav; 1992 May; 42(1):197-200. PubMed ID: 1356274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attenuation of hypothermic effects of ethanol by alpha 2-adrenoceptor blockers.
    Durcan MJ; Wozniak KM; Lister RG; Linnoila M
    Eur J Pharmacol; 1989 Aug; 166(3):381-6. PubMed ID: 2572427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of catecholamine effects during hypoglycaemia in man by urapidil and propranolol.
    Petersen KG; Katschker P; Kerp L
    Eur J Clin Pharmacol; 1989; 36(4):351-5. PubMed ID: 2567671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacodynamics and pharmacokinetics of intramuscular dexmedetomidine.
    Scheinin H; Karhuvaara S; Olkkola KT; Kallio A; Anttila M; Vuorilehto L; Scheinin M
    Clin Pharmacol Ther; 1992 Nov; 52(5):537-46. PubMed ID: 1358496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A preliminary, clinical pharmacological assessment of L-659,066, a novel alpha 2-adrenoceptor antagonist.
    Schafers RF; Elliott HL; Howie CA; Reid JL
    Br J Clin Pharmacol; 1992 Dec; 34(6):521-6. PubMed ID: 1362887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: I. Effects on blood pressure, heart rate and pressor responsiveness in normotensive subjects.
    Schafers RF; Elliott HL; Howie CA; Reid JL
    Br J Clin Pharmacol; 1991 Nov; 32(5):599-604. PubMed ID: 1683249
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the effects of desipramine on noradrenaline- and methoxamine-evoked venoconstriction in man.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1995 Nov; 40(5):445-51. PubMed ID: 8703648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebral glucose metabolic and plasma catecholamine responses to the alpha(2) adrenoceptor antagonist ethoxyidazoxan given to healthy volunteers.
    Schmidt ME; Oshinsky RJ; Kim HG; Schouten JL; Folley BS; Potter WZ
    Psychopharmacology (Berl); 1999 Sep; 146(2):119-27. PubMed ID: 10525746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of imidazoline and nonimidazoline alpha-adrenergic agents, including xylazine, medetomidine, yohimbine, tolazoline, and atipamezole, on aggregation of bovine and equine platelets.
    Yokota S; Hikasa Y; Shimura I; Kusunose S
    Am J Vet Res; 2013 Mar; 74(3):395-402. PubMed ID: 23438114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose-dependent alpha 1-adrenoceptor antagonist activity of the anti-arrhythmic drug, abanoquil (UK-52,046), without reduction in blood pressure in man.
    Tham TC; Guy S; Shanks RG; Harron DW
    Br J Clin Pharmacol; 1992 Apr; 33(4):405-9. PubMed ID: 1349492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological effects of medetomidine in humans.
    Scheinin H; Kallio A; Koulu M; Scheinin M
    Acta Vet Scand Suppl; 1989; 85():145-7. PubMed ID: 2571265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.